126 related articles for article (PubMed ID: 10354091)
1. Paronychia associated with antiretroviral therapy.
Tosti A; Piraccini BM; D'Antuono A; Marzaduri S; Bettoli V
Br J Dermatol; 1999 Jun; 140(6):1165-8. PubMed ID: 10354091
[TBL] [Abstract][Full Text] [Related]
2. Indinavir-related recurrent paronychia and ingrown toenails.
Alam M; Scher RK
Cutis; 1999 Oct; 64(4):277-8. PubMed ID: 10544885
[TBL] [Abstract][Full Text] [Related]
3. Lamivudine-induced paronychia.
Zerboni R; Angius AG; Cusini M; Tarantini G; Carminati G
Lancet; 1998 Apr; 351(9111):1256. PubMed ID: 9643757
[No Abstract] [Full Text] [Related]
4. [Paronychia in patients infected with HIV treated with indinavir].
García García MJ; Morano Amado LE; Allegue Rodríguez F; Miralles Alvarez C; Ocampo Hermida A
Rev Clin Esp; 2001 Aug; 201(8):455-8. PubMed ID: 11599157
[TBL] [Abstract][Full Text] [Related]
5. Paronychia in association with indinavir treatment.
Colson AE; Sax PE; Keller MJ; Turk BK; Pettus PT; Platt R; Choo PW
Clin Infect Dis; 2001 Jan; 32(1):140-3. PubMed ID: 11118393
[TBL] [Abstract][Full Text] [Related]
6. Indinavir-induced retinoid-like effects: incidence, clinical features and management.
García-Silva J; Almagro M; Peña-Penabad C; Fonseca E
Drug Saf; 2002; 25(14):993-1003. PubMed ID: 12408731
[TBL] [Abstract][Full Text] [Related]
7. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
AIDS; 2000 Mar; 14(4):367-74. PubMed ID: 10770538
[TBL] [Abstract][Full Text] [Related]
8. CT appearances of HIV-related lipodystrophy syndrome.
Gellett LR; Haddon L; Maskell GF
Br J Radiol; 2001 Apr; 74(880):382-3. PubMed ID: 11387159
[TBL] [Abstract][Full Text] [Related]
9. A pilot study of nevirapine, indinavir, and lamivudine among patients with advanced human immunodeficiency virus disease who have had failure of combination nucleoside therapy.
Harris M; Durakovic C; Rae S; Raboud J; Fransen S; Shillington A; Conway B; Montaner JS
J Infect Dis; 1998 Jun; 177(6):1514-20. PubMed ID: 9607828
[TBL] [Abstract][Full Text] [Related]
10. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
Hammer SM; Squires KE; Hughes MD; Grimes JM; Demeter LM; Currier JS; Eron JJ; Feinberg JE; Balfour HH; Deyton LR; Chodakewitz JA; Fischl MA
N Engl J Med; 1997 Sep; 337(11):725-33. PubMed ID: 9287227
[TBL] [Abstract][Full Text] [Related]
11. 3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine.
Gulick RM; Mellors JW; Havlir D; Eron JJ; Meibohm A; Condra JH; Valentine FT; McMahon D; Gonzalez C; Jonas L; Emini EA; Chodakewitz JA; Isaacs R; Richman DD
Ann Intern Med; 2000 Jul; 133(1):35-9. PubMed ID: 10877738
[TBL] [Abstract][Full Text] [Related]
12. Paronychia with pyogenic granuloma in a child treated with indinavir: the retinoid-mediated side effect theory revisited.
Sass JO; Jakob-Sölder B; Heitger A; Tzimas G; Sarcletti M
Dermatology; 2000; 200(1):40-2. PubMed ID: 10681612
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1-infected patients. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team.
Pialoux G; Raffi F; Brun-Vezinet F; Meiffrédy V; Flandre P; Gastaut JA; Dellamonica P; Yeni P; Delfraissy JF; Aboulker JP
N Engl J Med; 1998 Oct; 339(18):1269-76. PubMed ID: 9791142
[TBL] [Abstract][Full Text] [Related]
14. Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 Team.
Havlir DV; Marschner IC; Hirsch MS; Collier AC; Tebas P; Bassett RL; Ioannidis JP; Holohan MK; Leavitt R; Boone G; Richman DD
N Engl J Med; 1998 Oct; 339(18):1261-8. PubMed ID: 9791141
[TBL] [Abstract][Full Text] [Related]
15. Severe anoxic hepatic necrosis in an HIV-1-hepatitis C virus-co-infected patient starting antiretroviral triple combination therapy.
Karras A; Rabian C; Zylberberg H; Hermine O; Duchatelle V; Durand F; Valla D; Viard JP
AIDS; 1998 May; 12(7):827-9. PubMed ID: 9619823
[No Abstract] [Full Text] [Related]
16. Treatment and prevention of paronychia using a new combination of topicals: report of 30 cases.
Gianni C
G Ital Dermatol Venereol; 2015 Aug; 150(4):357-62. PubMed ID: 25854670
[TBL] [Abstract][Full Text] [Related]
17. Paronychia in patients receiving antiretroviral therapy for human immunodeficiency virus infection.
Sibel S; Macher A; Goosby E
J Am Podiatr Med Assoc; 2000 Feb; 90(2):98-100. PubMed ID: 10697975
[No Abstract] [Full Text] [Related]
18. Adherence to antiretroviral therapy and outcomes in HIV-infected patients enrolled in an induction/maintenance randomized trial.
Flandre P; Peytavin G; Meiffredy V; Saidi Y; Descamps D; Delagnes M; Brun-Vézinet F; Raffi F;
Antivir Ther; 2002 Jun; 7(2):113-21. PubMed ID: 12212923
[TBL] [Abstract][Full Text] [Related]
19. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy.
Gulick RM; Mellors JW; Havlir D; Eron JJ; Gonzalez C; McMahon D; Richman DD; Valentine FT; Jonas L; Meibohm A; Emini EA; Chodakewitz JA
N Engl J Med; 1997 Sep; 337(11):734-9. PubMed ID: 9287228
[TBL] [Abstract][Full Text] [Related]
20. Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial.
Staszewski S; Keiser P; Montaner J; Raffi F; Gathe J; Brotas V; Hicks C; Hammer SM; Cooper D; Johnson M; Tortell S; Cutrell A; Thorborn D; Isaacs R; Hetherington S; Steel H; Spreen W;
JAMA; 2001 Mar; 285(9):1155-63. PubMed ID: 11231744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
